ATRACURIUM Pfizer 10 mg/ml, solution for injection/for infusion 5 ampoules of 5 ml
Active ingredients: ATRACURIUM, BÉSILATE D'ATRACURIUM
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusion5 ampoules of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATRACURIUM Pfizer 10 mg/mL, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 6 Nov 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64612088CIP75713880CIP133400957138806Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉSILATE D'ATRACURIUMsolution | 10 mg · 1 ml | SA |
| ATRACURIUMsolution | 7,5 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: BÉSILATE D'ATRACURIUM 10 mg/ml - TRACRIUM 25 mg/2,5 ml (1 POUR CENT), solution injectable en ampoule
Group of similar medicines: BÉSILATE D'ATRACURIUM 10 mg/ml - TRACRIUM 50 mg/5 ml (1 POUR CENT), solution injectable en ampoule
Group of similar medicines: BÉSILATE D'ATRACURIUM 10 mg/ml - TRACRIUM 250 mg/25 ml, solution injectable